Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
58,228,856
-
Shares change
-
+1,947,174
-
Total reported value, excl. options
-
$458,218,605
-
Value change
-
+$9,215,236
-
Put/Call ratio
-
159%
-
Number of buys
-
63
-
Number of sells
-
-61
-
Price
-
$7.87
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2018
154 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q4 2018.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58,228,856 shares
.
Largest 10 shareholders include BlackRock Inc. (5,161,581 shares), BAKER BROS. ADVISORS LP (4,917,700 shares), Redmile Group, LLC (2,948,865 shares), Vanguard Group Inc (2,935,490 shares), EAGLE ASSET MANAGEMENT INC (2,852,973 shares), Foresite Capital Management IV, LLC (2,631,258 shares), PERCEPTIVE ADVISORS LLC (2,462,821 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,160,150 shares), BOXER CAPITAL, LLC (2,094,000 shares), and CARILLON TOWER ADVISERS, INC. (2,061,772 shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.